Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Genomics Market Size Worth USD 27.6 Billion by 2025 | CAGR: 9.1%: Grand View Research, Inc.
N
Nice Insight
Mar 15, 2019
PR-M03-19-NI-044-2861
Cell and Gene Therapy
Press Releases
Market Dynamics
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
Related Content
Cell Therapy
NueCell Bio Launches as a New Translational Partner to Accelerate Cell Therapies from Discovery into GMP Manufacturing
NueCell Bio
PR-08-26-01
Aug 5, 2026
In Vivo CAR-T
Five Companies Bringing In Vivo CAR-T Therapy Closer to the Clinic
Emma Gormlie
Nice Insight
PAO-07-26-PA-13
Jul 30, 2026
Stem Cells
Stem Cell Therapies: Close to Transforming Promise into Real Patient Outcomes
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-26-PA-11
Jul 22, 2026
In Vivo Selection
Repairing More Tissue Than You Edit: What In Vivo Selection Could Mean for Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-14
Jul 13, 2026
Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03
Jun 30, 2026
Genome Engineering
Aiming for More than Single-Base Corrections: The Technologies Opening the Genome to Therapeutic Cargo
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-16
Jun 29, 2026
Microbiome Editing
Editing the Microbiome in Place: From Engineered Probiotics to Programmable Ecological Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-15
Jun 22, 2026
Research Collab
10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer
10x Genomics
PR-06-26-02
Jun 17, 2026
CNS Clinical
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969
Insilico Medicine
PR-06-26-01
Jun 17, 2026
Pathfinder
Lipid Nanoparticles vs. Viral Vectors for Gene Delivery: Which Platform Is Better?
Pharma's Almanac
PAO-26-PF-11
Jun 12, 2026
Continuous VV
The Stepwise Future of Continuous Viral Vector Manufacturing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-12
Jun 1, 2026
Pathfinder
AAV vs. Lentiviral Vectors: Which Viral Vector Is Better for Gene Therapy?
Pharma's Almanac
PAO-26-PF-09
May 29, 2026
Previous slide
Next slide
